Skip to main content
. 2022 Jun 21;12:906778. doi: 10.3389/fonc.2022.906778

Table 2.

Comparison of demographic and clinical characteristics in HCC patients with information on HBV infection.

Variable Total (n = 12,824) Patients without HBV infection (n = 2,001) Patients with HBV infection (n = 10,823) P-value
Age (year)
 Medium (IQR) 53 (46-61) 60 (53-68) 52 (45-60)
 <40 1,356 (10.6) 103 (5.1) 1,253 (11.6) <0.001
 40–59 7,639 (59.6) 822 (41.1) 6,817 (63.0)
 ≥60 3,829 (29.8) 1,076 (53.8) 2,753 (25.4)
Gender
 Female 1,718 (13.4) 302 (15.1) 1,416 (13.1) 0.015
 Male 11,106 (86.6) 1,699 (84.9) 9,407 (86.9)
HCV
 Negative 9,710 (96.9) 1,480 (86.8) 8,230 (98.9) <0.001
 Positive 315 (3.1) 225 (13.2) 90 (1.1)
Cirrhosis
 No 5,762 (50.7) 1,052 (67.9) 4,710 (48.0) <0.001
 Yes 5,610 (49.3) 498 (32.1) 5,112 (52.0)
Ascites
 No 10,488 (96.6) 1,336 (95.5) 9,152 (96.8) 0.016
 Yes 370 (3.4) 63 (4.5) 307 (3.2)
BCLC stage
 0 451 (3.7) 47 (3.2) 404 (4.2) <0.001
 A 4,670 (39.6) 694 (47.7) 3,976 (41.4)
 B 4,018 (38.0) 518 (35.6) 3,500 (36.4)
 C 1,926 (18.7) 197 (13.5) 1,729 (18.0)
Tumor thrombus
 No 6,812(65.0) 875 (68.1) 5,937 (64.5) 0.011
 Yes 3,670(35.0) 409 (31.9) 3,261 (35.5)
Tumor nodule
 Single 8,084 (80.1) 987 (84.2) 7,097 (79.6) <0.001
 Multiple 2,003 (19.9) 185 (15.8) 1,818 (20.4)
Tumor diameter (cm)
 <3 1,644 (12.7) 175 (10.6) 1,298 (12.7) 0.007
 ≥3 9,950 (87.3) 1,469 (89.4) 8,652 (87.3)
Tumor capsule
 Yes 7,129 (70.8) 830 (70.6) 6,299 (70.8) 0.867
 No 2,942 (29.2) 346 (29.4) 2,596 (29.2)
AFP (ng/ml)
 <20 4,417 (37.6) 800 (49.9) 3,617 (35.6) <0.001
 ≥20 7,334 (62.4) 803 (50.1) 6,531 (64.4)
Total bilirubin (µmol/L)
 ≤23 9,483 (88.9) 1,152 (88.5) 8,331 (88.9) 0.635
 >23 1,188 (11.1) 150 (11.5) 1,038 (11.1)
Direct bilirubin (µmol/L)
 ≤8 8,444 (81.5) 965 (81.4) 7,479 (81.5) 0.976
 >8 1,921 (18.5) 220 (18.6) 1,701 (18.5)
Albumin (g/L)
 ≥40 6,555 (59.6) 912 (62.8) 5,643 (59.1) 0.007
 <40 4,451 (40.4) 541 (37.2) 3,910 (40.9)

Data are shown in n (%).